Amarantus Bioscience Holdings Inc (AMBS)

[brharris]

I agree 100%. This will create the buying pressure that has been missing.

Let's look at what's on tap for the next few weeks:
- next week is the official closing of the ESS acquisition

- the following week AMBS silver sponsor(cost $50k) to announce positive LymPro data at the AAIC

- the last week of July with the share price maintaining above $4 AMBS will qualify for NASDAQ uplist

- that will likely make IPO/uplist in early to mid August raising between $20 million - $150 million with the shelf offering

- mixed in that time frame we get first patient dosing for Eltoprazine Phase 2 trail and ESS Phase 2 trail initiating

Look at my post history, I am not one for predictions but I am gonna say the bottom is in!!